ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5%
Wed, 20 May

ASTRAZENECA PHARMA has announced its results for the quarter ended March 2020. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-19*
3
Dec-19*
3
Mar-20*
QoQ ChangeYoY Change
Net SalesRs m1,9032,2391,949-12.9%2.4%
Other incomeRs m603534-2.5%-43.8%
TurnoverRs m1,9632,2731,983-12.8%1.0%
ExpensesRs m1,8391,8711,801-3.7%-2.1%
Gross profitRs m64368148-59.7%132.5%
DepreciationRs m394845-4.7%16.3%
InterestRs m0335.5%0.0%
Profit before taxRs m85352134-62.0%57.6%
TaxRs m-148538-55.5%
Profit after taxRs m9826796-64.1%-2.5%
Gross profit margin%3.316.47.6
Effective tax rate%-15.924.128.3
Net profit margin%5.011.74.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 2.4% on a year-on-year (YoY) basis. The expenses were down by 2.1% YoY during the same period.
  • The company's operating profit increased by 132.5% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 7.6% in 4QFY20 as against 3.3% in 4QFY19.
  • Depreciation charges increased by 16.3% and finance costs increased by 0.0% YoY, respectively.
  • Other income declined by 43.8% YoY during the quarter.
  • Net profit for the quarter declined by 2.5% YoY. Net profit margins during the quarter declined from 5.0% in 4QFY19 to 4.8% in 4QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 12.9% on a quarter-on-quarter (QoQ) basis. The expenses were down by 3.7% QoQ during the same period.
  • The company's operating profit declined by 59.7% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 7.6% in 4QFY20 as against 16.4% in 3QFY19.
  • Net profit for the quarter declined by 64.1% QoQ, while net profit margins declined from 11.7% in 3QFY19 to 4.8% in 4QFY20.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters,please visit here.

FREE: Tanushree Banerjee's Controversial Event on Forever Stocks

ASTRAZENECA PHARMA Share Price Performance

Over the last one year,ASTRAZENECA PHARMA share price has moved up from Rs 2,291.9 to Rs 2,728.1, registering a Gain of Rs 436.2 or around 19.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 15,053.9 (up 1.1%). Over the last one year it has moved up from 13,341.1 to 15,053.9, a gain of 1,713 points (up 12.8%).

Overall, the S&P BSE SENSEX is down 22.8% over the year.

Current Valuations

At the current price of Rs 2,728.1, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 94.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 27.6 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5%". Click here!

  

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors(Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

My 'Unlock' Investments(Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

The Most Visible Sign of India's Revival is on Two Wheels(Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

Rs 2 Trillion Stimulus Coming to a Stock Market Near You(Profit Hunter)

Jun 2, 2021

Get ready to profit from a massive stimulus that you've never seen before.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Jun 15, 2021 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - AUROBINDO PHARMA COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS